Gold Rate

Vivimed Labs Ltd.

BSE: 532660 | NSE: VIVIMEDLAB | Series: NA | ISIN: INE526G01021 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Vivimed Labs L Vivimed Labs Ltd. | BSE 4.90 -0.20 (-3.92%) | NSE 4.95 0.00 (0.00%) | Trade | Add

BSE Live

Jul 31, 16:01

4.90 -0.20 (-3.92%)

Volume

AVERAGE VOLUME

5-Day

35,787

10-Day

32,918

30-Day

30,014

20,639

Prev. Close

5.10
Open Price

5.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jul 31, 15:40

4.95 0.00 (0.00%)

Volume

No Data Available

Prev. Close

4.95
Open Price

5.25

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Vivimed Labs is not traded on NSE in the last 30 days

Financials

Print/Copy to Excel : Go

Profit & Loss account of Vivimed Labs (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	987.53	1,264.91	1,181.18	1,224.91	1,345.43
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	987.53	1,264.91	1,181.18	1,224.91	1,345.43
Total Operating Revenues	1,058.80	1,315.17	1,185.66	1,461.91	1,345.63
Other Income	8.26	22.96	9.61	8.09	10.81
Total Revenue	1,067.06	1,338.13	1,195.27	1,470.00	1,356.44
EXPENSES
Cost Of Materials Consumed	483.24	561.91	489.80	565.83	609.69
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	0.00
Operating And Direct Expenses	244.56	258.10	209.34	207.23	205.57
Changes In Inventories Of FGWIP And Stock In Trade	-20.69	-43.51	-10.13	-29.55	14.36
Employee Benefit Expenses	233.36	241.76	197.78	189.98	176.94
Finance Costs	58.89	67.26	79.48	65.87	81.57
Depreciation And Amortisation Expenses	66.95	66.79	56.42	58.28	61.39
Other Expenses	110.23	119.78	86.87	125.89	106.99
Total Expenses	1,176.53	1,272.09	1,109.56	1,183.52	1,256.51
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-109.47	66.05	85.71	286.48	99.93
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	-109.47	66.05	85.71	286.48	99.93
Tax Expenses-Continued Operations
Current Tax	3.80	7.80	12.18	74.10	16.12
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-4.16	0.88	-2.56	-1.59	0.14
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-0.36	8.68	9.62	72.50	16.26
Profit/Loss After Tax And Before ExtraOrdinary Items	-109.12	57.37	76.09	213.98	83.67
Profit/Loss From Continuing Operations	-109.12	57.37	76.09	213.98	83.67
Profit/Loss For The Period	-109.12	57.37	76.09	213.98	83.67
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	-109.12	57.37	76.09	213.98	83.67
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	-13.00	7.00	9.00	26.00	52.00
Diluted EPS (Rs.)	-13.00	7.00	9.00	26.00	50.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	329.56	3.95	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00